Semaglutide has robust randomized trial evidence and an FDA weight loss indication
The MCHR1 antagonist NGD-4715 was safe and well-tolerated in a Phase I clinical trial, but its development ceased in 2013
Methionine, inositol, and choline work together to help the body process and mobilize fat rather than store it
BPC-157 (Body Protective Compound-157) Research Wound Healing & Collagen Formation (PubMed / ScienceDirect, 1997) One of the earliest published studies of BPC-157s tissue effects used three experimental rat models skin incisional wounds, colon-colon anastomoses, and synthetic sponge implantation to assess its influence on granulation tissue formation, collagen production, angiogenesis, and tensile strength development
BPC-157 was shown in rat models to combat heart failure via the NO system, echoing emerging gene therapy modalities in ED treatment
These mechanisms support the consistent findings with joint, gut, and soft tissue models